Homeostasis of the ER redox state subsequent to proteasome inhibition
Oku, Yuki, Kariya, Masahiro, Fujimura, Takaaki, Hoseki, Jun, Sakai, Yasuyoshi
Published in Scientific reports (21.04.2021)
Published in Scientific reports (21.04.2021)
Get full text
Journal Article
Development of a stable ERroGFP variant suitable for monitoring redox dynamics in the ER
Hoseki, Jun, Oishi, Asami, Fujimura, Takaaki, Sakai, Yasuyoshi
Published in Bioscience reports (01.04.2016)
Published in Bioscience reports (01.04.2016)
Get full text
Journal Article
Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulation
Yamashita-Kashima, Yoriko, Shu, Sei, Osada, Masahiro, Fujimura, Takaaki, Yoshiura, Shigeki, Harada, Naoki, Yoshimura, Yasushi
Published in Cancer chemotherapy and pharmacology (01.11.2020)
Published in Cancer chemotherapy and pharmacology (01.11.2020)
Get full text
Journal Article
Coadministration with bendamustine restores the antitumor activity of obinutuzumab in obinutuzumab-resistant tumors
Yamashita-Kashima, Yoriko, Yorozu, Keigo, Fujimura, Takaaki, Kawasaki, Natsumi, Kurasawa, Mitsue, Yoshiura, Shigeki, Harada, Naoki, Kondoh, Osamu, Yoshimura, Yasushi
Published in International journal of hematology (01.06.2022)
Published in International journal of hematology (01.06.2022)
Get full text
Journal Article
Correction to: Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulation
Yamashita‑Kashima, Yoriko, Shu, Sei, Osada, Masahiro, Fujimura, Takaaki, Yoshiura, Shigeki, Harada, Naoki, Yoshimura, Yasushi
Published in Cancer chemotherapy and pharmacology (01.07.2021)
Published in Cancer chemotherapy and pharmacology (01.07.2021)
Get full text
Journal Article
Enhanced antitumor effect of alectinib in combination with cyclin-dependent kinase 4/6 inhibitor against RET-fusion-positive non-small cell lung cancer cells
Fujimura, Takaaki, Furugaki, Koh, Harada, Naoki, Yoshimura, Yasushi
Published in Cancer biology & therapy (01.09.2020)
Published in Cancer biology & therapy (01.09.2020)
Get full text
Journal Article
INHIBITOR OF CELL PROLIFERATION IN OBINUTUZUMAB RESISTANT CD20-POSITIVE CANCER, AND MEDICINAL COMPOSITION, MEDICINE, PRODUCTION, METHOD FOR INHIBITING CELL PROLIFERATION, THERAPEUTIC METHOD, TYPE II ANTI-CD20 ANTIBODY, COMPOUNDS, COMBINATION OF SAME, ENHANCER AND INDUCER, EACH RELATING THERETO
Get full text
Patent
Obinutuzumab in Combination with Chemotherapy Enhances Direct Cell Death in CD20-Positive Obinutuzumab-resistant Non-Hodgkin Lymphoma Cells
Fujimura, Takaaki, Yamashita-Kashima, Yoriko, Kawasaki, Natsumi, Yoshiura, Shigeki, Harada, Naoki, Yoshimura, Yasushi
Published in Molecular cancer therapeutics (01.06.2021)
Published in Molecular cancer therapeutics (01.06.2021)
Get full text
Journal Article
Resistance to obinutuzumab-induced antibody-dependent cellular cytotoxicity caused by abnormal Fas signaling is overcome by combination therapies
Kawasaki, Natsumi, Yamashita-Kashima, Yoriko, Fujimura, Takaaki, Yoshiura, Shigeki, Harada, Naoki, Kondoh, Osamu, Yoshimura, Yasushi
Published in Molecular biology reports (01.06.2022)
Published in Molecular biology reports (01.06.2022)
Get full text
Journal Article
Obinutuzumab-Retreatment in Combination with Bendamustine Is Effective for Obinutuzumab Resistant Models in Vitro and In Vivo
Yamashita-Kashima, Yoriko, Kawasaki, Natsumi, Yorozu, Keigo, Yoshiura, Shigeki, Fujimura, Takaaki, Kurasawa, Mitsue, Harada, Naoki, Yoshimura, Yasushi
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Molecular targeting of HER2-overexpressing biliary tract cancer cells with trastuzumab emtansine, an antibody–cytotoxic drug conjugate
Yamashita-Kashima, Yoriko, Yoshimura, Yasushi, Fujimura, Takaaki, Shu, Sei, Yanagisawa, Mieko, Yorozu, Keigo, Furugaki, Koh, Higuchi, Ryota, Shoda, Junichi, Harada, Naoki
Published in Cancer chemotherapy and pharmacology (01.04.2019)
Published in Cancer chemotherapy and pharmacology (01.04.2019)
Get full text
Journal Article
Preclinical study of antitumor activity of trastuzumab emtansine in HER2-positive biliary tract cancer
Yamashita-Kashima, Yoriko, Fujimura, Takaaki, Shu, Sei, Yanagisawa, Mieko, Mochizuki, Marie, Yorozu, Keigo, Kouno, Mirei, Furugaki, Koh, Higuchi, Ryota, Shoda, Junichi, Harada, Naoki, Yoshimura, Yasushi
Published in Journal of clinical oncology (01.02.2018)
Published in Journal of clinical oncology (01.02.2018)
Get full text
Journal Article
INHIBITOR OF CELL PROLIFERATION IN OBINUTUZUMAB RESISTANT CD20-POSITIVE CANCER, AND MEDICINAL COMPOSITION, MEDICINE, PRODUCTION, METHOD FOR INHIBITING CELL PROLIFERATION, THERAPEUTIC METHOD, TYPE II ANTI-CD20 ANTIBODY, COMPOUNDS, COMBINATION OF SAME, ENHANCER AND INDUCER, EACH RELATING THERETO
Get full text
Patent
Inhibitor of cell proliferation in obinutuzumab resistant CD20-positive cancer, and medicinal composition, medicine, production, method for inhibiting cell proliferation, therapeutic method, type II anti-CD20 antibody, compounds, combination of same, enhancer and inducer, each relating thereto
Get full text
Patent